Atlas Trials

A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease

Clinical trial NCT05435729 · COMPLETED

Trial details

NCT number
NCT05435729
Sponsor
Sumitomo Pharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Levodopa-induced DyskinesiaParkinson's Disease
Start date
2022-05-31
Primary completion
2022-11-30
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.